| UHC UMR Medical and Drug | Minimally Invasive Spine Surgery Procedures – Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Respiratory Interleukins (Cinqair®, Fasenra®, & Nucala®) - Commercial Medical Benefit Drug Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Tepezza® (Teprotumumab-Trbw) – Commercial Medical Benefit Drug Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Tezspire® (Tezepelumab-Ekko) – Commercial Medical Benefit Drug Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Total Artificial Disc Replacement for the Spine – Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC Surest Medical and Drug | Ablative Treatment for Spinal Pain – Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC Surest Medical and Drug | Breast Imaging for Screening and Diagnosing Cancer – Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC Surest Medical and Drug | Cimzia® (Certolizumab Pegol) – Commercial Medical Benefit Drug Policy | 2026-02-01 |
| UHC Surest Medical and Drug | Computer-Assisted Surgical Navigation for Musculoskeletal Procedures – Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC Surest Medical and Drug | Deep Brain and Cortical Stimulation – Commercial and Individual Exchange Medical Policy | 2026-02-01 |